Phase I trial of fractionated-dose 177Lutetium radiolabeled antiprostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) for metastatic castration-resistant prostate cancer (CRPC) Meeting Abstract
| Authors: | Tagawa, S. T.; Akhtar, N. H.; Nikolopoulou, A.; Vallabhajosula, S.; Osborne, J.; Beltran, H.; Kahn, R.; Goldsmith, S. J.; Nanus, D. M.; Bander, N. H. |
| Abstract Title: | Phase I trial of fractionated-dose 177Lutetium radiolabeled antiprostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) for metastatic castration-resistant prostate cancer (CRPC) |
| Meeting Title: | 17th European Cancer Conference (ECCO 17) |
| Journal Title: | European Journal of Cancer |
| Volume: | 49 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Sep 27-Oct 1 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-09-01 |
| Start Page: | S701 |
| End Page: | S702 |
| Language: | English |
| ACCESSION: | WOS:000326843604277 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(13)70064-9 |
| Notes: | Meeting Abstract: 2915 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos |
